We have recently shown that tobacco smoking, like ultraviolet A radiation, is an important factor contributing to premature skin aging. We found that tobacco smoke extract decreased type I and III procollagen, increased tropoelastin mRNA, and induced abnormal accumulation of proteoglycans and matrix metalloproteinase (MMP)-1 and MMP-3 in cultured skin fibroblasts. This indicated that common molecular features might underlie the premature aging of the skin induced by tobacco smoke extract, including abnormal regulation of extracellular matrix deposition through elevated MMPs, reduced collagen production, abnormal tropoelastin accumulation, and altered proteoglycans. With the exception that reactive oxygen species were mediated in the aging process, transforming growth factor (TGF)-beta1 was found to play a crucial role in the age-related alterations induced by tobacco smoke extract. Here we report that tobacco smoke extract blocks cellular responsiveness to TGF-beta1 through the induction of a non-functional latent form of TGF-beta1, and downregulation of the TGF-beta1 receptor. This paper shows the evidence for the role of tobacco smoking in skin aging and describes how modulation of TGF-beta1 levels might retard premature skin aging.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1034/j.1600-0625.12.s2.8.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
How adolescent tobacco use has responded to state tobacco 21 laws and flavor restrictions.
Am J Drug Alcohol Abuse
March 2025
School of Social Work, Boston College, Chestnut Hill, MA, USA.
Tobacco 21 (T21) laws (prohibiting tobacco sales under age 21) and flavor restrictions have recently been enacted, yet little is known about the extent to which these policies shifted adolescent tobacco use. To examine the associations between state-level T21 laws and flavor restrictions with adolescent tobacco use overall and by age. We linked state-level T21 laws and flavor restrictions with individual-level data on self-reported levels of cigarette, cigar, and electronic nicotine delivery systems (ENDS) use among 979,477 (500,205 female/479,272 male) 14-18+-year-olds from the 2011-2021 Youth Risk Behavior Surveys.
View Article and Find Full Text PDFThe impacts of product characteristics and regulatory environment on smokers' preferences for tobacco and alcohol: Evidence from a volumetric choice experiment.
PLoS One
March 2025
Department of Population Health Sciences, School of Public Health, Georgia State University Atlanta, Atlanta, Georgia, United States of America.
Objective: Concurrent use of alcohol and cigarettes is well-documented in the literature. However, it is unclear how e-cigarette regulations in a growing number of localities impact the use of tobacco and alcohol in the US. This study aims to evaluate the impacts of excise taxes, tobacco use restrictions in restaurants/bars, and availability of alcohol flavor in e-cigarettes on tobacco consumption, and their cross impacts on alcohol consumption.
View Article and Find Full Text PDFNicotine Exposure From Smoking Tobacco and Vaping Among Adolescents.
JAMA Netw Open
March 2025
Department of Addictions, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Importance: It remains unknown whether nicotine intake among youths who vape is lower, comparable, or higher than among youths who smoke.
Objective: To examine potential differences in biomarkers of exposure to nicotine (1) between adolescents who smoke tobacco, vape, both vape and smoke (dual use), or do not use; (2) between adolescents in 3 countries; and (3) by nicotine content and form in the vaping product last used among adolescents who exclusively vaped.
Design, Setting, And Participants: This population-based, observational cross-sectional study invited adolescents aged 16 to 19 years in Canada, England, and the US who had previously completed national surveys to participate in a biomarker study based on their vaping and smoking status.
Facilitators and barriers to implementing smoke-free homes in Armenia: a qualitative study.
Glob Health Promot
March 2025
Department of Prevention and Community Health, Milken Institute School of Public Health; George Washington Cancer Center; George Washington University, Washington, DC, USA.
Smoke-free homes (SFHs) reduce secondhand smoke exposure (SHSe), which is particularly crucial where smoking prevalence is high and public smoke-free policies are nascent, as in some low- and middle-income countries (LMICs). This study examined perspectives regarding SFHs, including barriers and facilitators, among adults in Armenia, a LMIC with high male smoking prevalence and recently-implemented smoke-free policies. In February-March 2024, focus groups were conducted with adults reporting smoking and non-smoking, separately, in two Armenian communities ( = 39; = 41.
View Article and Find Full Text PDFBehavioral activation for smoking cessation in veterans with posttraumatic stress disorder: A randomized clinical trial.
Nicotine Tob Res
March 2025
Center for Tobacco Research and Intervention, University of Wisconsin Madison School of Medicine and Public Health, 1930 Monroe St #200, Madison, WI 53711.
Introduction: Certain psychiatric populations have especially low smoking cessation rates. This highlights the need to identify smoking treatments that increase cessation rates by addressing factors thought to impede their success. Behavioral activation (BA) targets anhedonia (i.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!